News and updates
EHA-ECL led statement calls for protection of the Hospital Exemption
The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.
Urgent action needed to avoid widespread shortage of in-vitro diagnostic tests
In a new statement, BioMed Alliance highlights its increasing concern about the availability of In Vitro Diagnostic (IVD) testing devices in Europe.
Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU adv…
Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.
FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) …
We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy…
Belgium shares EU health priorities for Council Presidency
On December 8, Belgium held a conference to unveil its program for the upcoming Council of the EU Presidency (website), to start on January 1, 2024.
Commonalities and Differences in Myeloid Malignancies: Insights from the EHA-SWG…
November 2-4 - Budapest, Hungary Meeting Chairs: Konstanze Döhner, University Hospital Ulm, Germany Claire Harrison, Guy's and St.
Connecting experts on inherited anemias and iron defects in Budapest
October 12-14, 2023 – Budapest, Hungary Meeting Chairs: Ali Taher, American University of Beirut Medical Center, Beirut, Lebanon Achille Iolascon, University Federico II of Naples, Naples, Italy In October 2023 EHA and the Specialized…
Highlights of Past EHA (HOPE) Latin America (LA) 2023 - report
October 26, 2023 – São Paulo, Brazil Meeting chairs: A Almeida - President EHA JF Comenalli Marques Jr - President ABHH C Chiattone - President HEMO 2023 This year, the HOPE LA meeting was held…
EHA response to the EU’s Pharma Revision
Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation.
CarrerasLeaders call two is now open
The second CarrerasLeaders call is open: apply now to the postdoctoral program to empower future leaders in the fight against blood cancers.
Hematology and oncology, pacemakers for EU HTA
EHA’s Martin Kaiser, right, addressing his fellow panelists. Left to right: Brian Cuffel (Bayer), Caroline Pothet (EMA), Roisin Adams (HTA CG), Bernhard Wörmann (DGHO) and Elisabeth de Vries (ESMO).
Statement
The European Hematology Association (EHA), a dedicated community of healthcare professionals, who work tirelessly "Towards prevention, cure, and quality of life for all patients with blood disorders", expresses its deep…
EHA Statement on the Erasmus MC Attack
EHA is deeply saddened and appalled by the news of the twin shootings in Rotterdam, the Netherlands. We condemn these senseless acts of violence in the strongest possible terms.
Statement of Solidarity after Earthquake in Morocco
On behalf of the European Hematology Association, I would like to express my deepest condolences and heartfelt support to the people of Morocco who have been affected by the recent…
EHA welcomes European Parliament backing for SoHO legislation
EHA welcomes the European Parliament’s backing for SoHO legislation that puts patient safety and supply sustainability first.